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Abstract
It has long been a quest in ruminants to understand how two very similar mycobacterial spe-
cies,Mycobacterium avium ssp. paratuberculosis (MAP) andMycobacterium avium ssp.
avium (MAA) lead to either a chronic persistent infection or a rapid-transient infection,
respectively. Here, we hypothesized that when the host immune response is activated by
MAP or MAA, the outcome of the infection depends on the early activation of signalingmole-
cules and host temporal gene expression. To test our hypothesis, ligated jejuno-ileal loops
including Peyer’s patches in neonatal calves were inoculated with PBS, MAP, or MAA. A
temporal analysis of the host transcriptomeprofile was conducted at several times post-
infection (0.5, 1, 2, 4, 8 and 12 hours).When comparing the transcriptional responses of
calves infected with the MAA versus MAP, discordant patterns of mucosal expression were
clearly evident, and the numbers of unique transcripts altered were moderately less for
MAA-infected tissue than were mucosal tissues infected with the MAP. To interpret these
complex data, changes in the gene expression were furtheranalyzed by dynamic Bayesian
analysis. Bayesian networkmodeling identifiedmechanistic genes, gene-to-gene relation-
ships, pathways and Gene Ontologies (GO) biological processes that are involved in spe-
cific cell activation during infection. MAP and MAA had significant different pathway
perturbationat 0.5 and 12 hours post inoculation. Inverse processes were observed
betweenMAP and MAA response for epithelial cell proliferation, negative regulation of che-
motaxis, cell-cell adhesionmediated by integrin and regulation of cytokine-mediated signal-
ing. MAP inoculated tissue had significantly lower expression of phagocytosis receptors
such as mannose receptor and complement receptors. This study reveals that perturbation
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of genes and cellular pathways duringMAP infection resulted in host evasion by mucosal
membrane barrierweakening to access entry in the ileum, inhibition of Ca signaling associ-
ated with decreased phagosome-lysosome fusion as well as phagocytosis inhibition, bias
toward Th2 cell immune response accompanied by cell recruitment, cell proliferation and
cell differentiation; leading to persistent infection. Contrarily, MAA infection was related to
cellular responses associated with activation of molecular pathways that release chemicals
and cytokines involved with containment of infection and a strong bias toward Th1 immune
response, resulting in a transient infection.
Introduction
Mycobacterium avium ssp paratuberculosis (MAP) infection in cattle is established following
the ingestion of bacteria, invasion of the intestinal mucosa, and subsequent events of the host-
pathogen interaction. These bacteria invade M cells and macrophages, and are capable of
resisting host defenses, and multiply to reach very high intracellular numbers leading to
chronic granulomatous enteritis known as “Johne’s disease” in cattle.Mycobacterium avium
ssp avium (MAA) is antigenically and genetically similar organism to MAP, but is relatively
nonpathogenic for cattle [1–3]. MAP infectionmay have severe economic impact in dairy, as
well as, meat production industry. This economic loss may be due to the low milk and meat
production, weight loss, premature culling, increasedmortality, infertility, predisposition to
other diseases, and cost associated with replacement of animals, diagnostic tests administra-
tion, veterinary care, animal welfare and public-health issues [4, 5]. The phylogenetic analysis
ofMycobacterium avium subspecies revealed that MAP and MAA do not cluster together,
rather they are independently evolved clones [6, 7]. Upon interaction with the immune cells,
MAP may be killed or survive in the macrophages. If MAP survives in the macrophage, it trig-
gers adaptive immune responses and persists in the infected animals. This persistent infection
typically mounts an effective systemic immune response; however, this occurs during the late
stage of infection and results in enteric granulomatous inflammation.Whereas MAA infection
to cattle generally results in an effective immune response and elimination of pathogen. Despite
95% genomic similarity betweenMAP and MAA, what causes the persistent vs. transient infec-
tion in cattle is not fully understood. Several studies have focused on the role of mononuclear
phagocytes duringMAP and MAA infection [8–11]. These studies showed that MAA was a
stronger activating factor for phagocytic cells than MAP. Furthermore,MAP causes only an
early transient activation of MAPK-p38 in bovinemononuclear phagocytes that may be a key
mechanism involved in the capacity of MAP to survive in bovine monocytes. Bovinemono-
cytes or monocyte-derivedmacrophages incubated with MAP lead to a rapid phosphorylation
of MAPK-p38, higher expression of IL-10, and failure to acidify phagosomes or kill the organ-
isms [12]. In contrast, MAA-infected monocytes expressed low levels of IL-10, partially acidi-
fied phagosomes, and killed approximately half of the organisms within 96 hours. The
outcome of the disease depends on the interaction and collective response of various cell types
that are present at the mucosal surface. However, little emphasis has been given to the other
cell types duringMAP or MAA infection.Moreover, which components of host response are
involved in the activation of innate immunity is not very well defined in chronic infections.
Thus, a more comprehensive knowledge is needed regarding the pathogen interaction within
the enteric milieu that includes several other cell types, such as, enterocytes,M cells, dendritic
cells, goblet cells, endothelial cells, natural killer cells, mast cells and more. Toward this goal,
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we utilized the calf ligated jejuno-ileal loop model for analyzing early changes at the mucosal
surface duringMAP infection [13, 14]. Aim of the present study was to compare temporal
gene expression duringMAP and MAA infection in the calf jejuno-ilealmucosa, including
Peyer’s patches of calves infected with MAP or MAA. This comparison was done against same
control. Thus, this analysis provided us specific gene that were differentially regulated during
infectionwith MAP or MAA; so we were able to generate a comparative analysis regarding per-
sistent vs transient responses. A systems biology approach was applied to analyze the data
which enabled us to predict specific cell type involvement as well as specific cellular pathway
perturbations during the early infection. Furthermore, we identified innate immune signatures
(mechanistic genes) sufficient to envisage the subsequent adaptive immune response leading to
persistent or transient infection by MAP and MAA respectively.
Materials andMethods
Most of the materials and methods are essentially the same as described earlier by our group
[14]. For clarity of this publication some portions are reproduced from the earlier article and
cited accordingly.
Culture of MAP andMAA
Mycobacterium avium ssp paratuberculosis (ATCC 19698 from American Type Culture Col-
lection,Manassas, VA), was grown at 37°C in 7H9 broth (Difco Laboratories, Detroit, MI) sup-
plemented with 2.5% (vol/vol) glycerol (Sigma Chemical Co., St. Louis, MO), oleic acid-
albumin-dextrose-catalase (Difco Laboratories, Detroit, MI), 0.05% Tween 80 (Sigma Chemical
Co., MO), and 2 mg of Mycobactin J (AlliedMonitor, Inc., Fayette, MO).Mycobacterium
avium ssp avium (ATCC 35716 from American Type Culture Collection,Manassas, VA) was
grown at 37°C in 7H9 broth supplemented with 2.5% (vol/vol) glycerol, oleic acid-albumin-
dextrose-catalase and 0.05% Tween 80. For inoculation of MAP and MAA, single-cell suspen-
sions and counting was done as describedpreviouly [15].
Animals
Three to four weeks old, clinically healthy male Holstein-Friesian calves (n = 4) weighing 45–
55 kg, were used in the experiment under an approved animal use protocol in accordance with
animal use policy under the supervision of the Texas A &MUniversity Institutional Animal
Care and Research Advisory Committee (AUP 2007–70). The calves were fed antibiotic-free
milk replacer twice daily and water ad libitum. Animals included in this study were culture
negative for the presence of Salmonella spp. and pre-existence of mycobacterial species [14,
15].
Bovine Ligated Jejuno-ileal Loop Surgery
The method used for the bovine ligated jejuno-ileal loop surgery was almost the same as
describedpreviously [14]. Briefly, the neonatal calves were fasted for 24 hours prior to the non-
survival surgery, anesthetized and maintained analgesic for the course of the 12 hr experiment
[14]. The abdominal wall was clipped, prepared aseptically with chlorhexidine and isopropanol
prior to opening. The abdominal wall was incised and the entire length of the Peyer’s patch of
the distal jejunum and ileum exteriorized. Eighteen 6–8 cm loops of the distal jejunum and
ileumwere ligated with umbilical tape with 1–2 cm interloop spaces continuously. Individual
loops were injected with 1.0 ml of PBS containing 3x109 CFU of MAP or MAA. The same vol-
ume of sterile PBS was inoculated into the control loops. The loops were replaced into the
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abdominal cavity, and the incision temporarily closed with Backhaus towel clamps. Intrave-
nous 2.5% dextrose and 0.45% normal physiological was used to maintain circulating blood
volume at 5 ml/kg/hour. At 0.5, 1, 2, 4, 8 and 12 hours after bacterial inoculation, one each of
control, MAP and MAA loops were excised. Samples for bacteriologic culture and RNA extrac-
tion were collected as describedbelow. Electrocauterywas used to control hemorrhage after
excision of loops. During the entire length of experimental procedure, the calves were moni-
tored for vital signs (anesthesia depth, temperature blood pressure, heart rate and hydration
status,). At the end of the experiment (12 hours post infection), the calves were humanely
euthanized with a single bolus dose (60mg/lb IV) of pentobarbital sodium.
Bacteriology
Two mucosal tissue punches (6 mm biopsy punch) were collected from each loop (for bacteri-
ology. Mucosal tissue punches (two tissue punches from each loop) were washed three times in
PBS, weighed, homogenized in PBS, and serially diluted. The tissue extracts were plated in trip-
licate onto Herrold Egg Yolk Media containing ANV (BectonDickinson and Company,
Sparks, MD) with or without Mycobactin J (for the culture of MAP or MAA respectively) and
incubated at 37°C. The cultures were observed visually weekly for any contamination, and the
final counts of colony forming units were recorded on week 16. Colonization of tissue was con-
sidered to be positive when bacterial colonies were detected. Tissue burden was defined as the
number of colony forming units per milligramof tissue. The statistical significance of differ-
ences was calculated using two-tailed Student’s t test.
Extraction and Quality Analysis of RNA
RNA was extracted from the mucosal biopsy punches collected at 30 minutes and at 1, 2, 4, 8,
and 12 hr post-infection. In brief, tissue was immediately minced and transferred to Trizol
reagent (Molecular Research Center, Cincinnati, OH). Tissues were further disrupted with
hand-held mechanical tissue grinder equipped with a RNase, DNase free plastic disposable pes-
tle. The RNA extractionwas performed using the recommended protocol from the manufac-
turer (Molecular Research Center, Cincinnati, OH). The resultant RNA pellet was re-
suspended in DEPC-treated water (Ambion, Austin, TX). Genomic DNA was removed by
RNase-free DNase I treatment (DNA-free, Ambion) according to the manufacturer’s instruc-
tions, and samples were stored at −80°C until used. RNA concentration was quantified by mea-
suring absorbance at λ260nm using a NanoDrop1 ND-1000 (NanoDrop, Wilmington, DW).
RNA quality was determined using a Nano-Chip1 on an Agilent 2100 Bioanalyzer (Agilent,
Palo Alto, CA). All the RNA samples used in this study were of good to excellent quality
(results not shown). Samples were characterized by distinct 18S and 28S rRNA peaks and RNA
size distribution. Ten micrograms of RNA were used as startingmaterial for each microarray.
Bovine reference RNA was used as a control for each microarray [14]. Individual microarrays
for individual calves and individual time point were performed (4 animals  6 time points  3
test material = 72 microarrays)
Microarray Sample Preparation and Hybridization to Bovine cDNA
Microarray
Labeling of cDNA and hybridization to microarray has been described, previously [14, 16, 17].
Briefly, the total RNA was reverse transcribed using Superscript III reverse transcriptase (Invi-
trogen, Carlsbad, CA) and labeled with amino-allyl-UTP (Ambion, Austin, TX). Cy3 and Cy5
dye esters were covalently linked to the amino-allyl group by incubating the samples with the
dye esters in 0.1M sodium carbonate buffer. cDNA from bovine experimental samples (i.e.
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fromMAP or MAA infected) and PBS control loops were co-hybridized against cDNA gener-
ated from the bovine reference RNA sample 13K bovine 70mer oligoarray. Prior to hybridiza-
tion, the microarrays were denatured by exposing to steam from boiling water for three
seconds, UV cross-linked and then immersed in pre-hybridization buffer [5X sodium chloride,
sodium citrate buffer (SSC), 0.1% sodium dodecyl sulfate (SDS) (Thermo Fisher Scientific,
Waltham, MA), 1% bovine serum albumin (BSA)] at 42°C for a minimum of 45 min followed
by four washes in RNase-, DNase-free, distilledwater, immersion in 100% isopropanol for 10
seconds, and dried by centrifugation. Slides were hybridized at 42°C for approximately 40 hr in
a dark humid chamber (Corning, Corning, NY) and washed for 10 min at 42°C with low strin-
gency buffer [1 X SSC, 0.2% SDS] followed by two 5 min washes in a higher stringency buffer
[0.1 X SSC, 0.2% SDS and 0.1 X SSC] at room temperature in dark with mild agitation.
Data Acquisition
Immediately after washing, the slides were scanned using a GenePix 4100 laser scanner (Axon
Instruments Inc., Foster City, CA). The spots representing genes on the arrays were adjusted
for background and normalized to internal controls using image analysis software (GenePixPro
4.0; Axon Instruments Inc.). Spots with fluorescent signal values below background were disre-
garded in all analyses.
Microarray Data Analysis
The analysis of microarray data utilized a suite of systems biology computational tools inte-
grated within the Systems Biology Computational Pipeline (SBCP) (Seralogix LLC, Austin,
Texas). SBCP facilitates an approach employing Bayesian methods calledDynamic Bayesian
Gene Group Activation (DBGGA) for pathway and Gene Ontology (GO) analysis and model-
ing at the systems biology level offering an integrated view of biologicalmechanisms and net-
works of interactions. DBGGA determines pathway/GO activations and repressions as well as
mechanistic genes, which are genes that contribute the most to the perturbation of a pathway
in context within the network and gene-to-gene relationships. The SBCP integrates data from
several different heterogeneous database sources such as Gene Ontology (GO) Consortium
[18], Genbank (www.ncbi.nlm.nih.gov/Genbank), Ensembl, KEGG [19–22], and others such
that the cumulative modeling information provides greater biological insight. For differential
gene analysis, the SBCP employs a Bayesian estimation method with variance smoothing to
compute Z-scores (Bayesian Z-score), fold change and p-values. Details of these methods have
been described earlier [14, 23] and a brief overviewprovided in S1 File.
Microarray data deposited in the Gene ExpressionOmnibus
All microarray data were deposited in the Gene Expression Omnibus at the National Center
for Biotechnology Information (www.ncbi.nlm.nih.gov/geo/) Accession # GSE13888.
Results
Invasion of Jejunal and Jejuno-ilealMucosa by MAP andMAA
MAP and MAA were recovered from the MAP-inoculated jejuno-ileal tissues at all the time
points post infection (Fig 1). No MAP or MAA were detected in the PBS inoculated loops. No
statistically significant changes in the number of MAP or MAA were detected in infected jeju-
nal and jejuno-ileal tissues at any times post-inoculation (0.5–12 hours), however, MAA recov-
ery was higher as compared to MAP from all the tissue samples.
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Sequential changes in the transcriptional profile of bovine host Peyer’s
patches inoculatedwith MAP or MAA
Global gene expression analysis was performed using the RNA extracted from the mucosa of
the Peyer’s patch of the distal small intestine (jejunum and ileum) of four calves at six time
points post inoculation (30 minutes, 1, 2, 4, 8 and 12 hours) with MAP or MAA and compared
with gene expression in loops inoculatedwith PBS (for same time point) as an experimental
control. For the normalization of microarray data, bovine reference RNA, as described earlier
was used with each sample [14].
We analyzed the data to determine differences between experimental conditions (MAP vs
PBS or MAA vs PBS) and obtain detailed insight into the temporal relationships of various
genes using the SBCP Bayesian Z score technique (Table 1). These Z-scores were computed
after outlier removal ( 3 std. dev.) and filtered based on a significance of |Z-score| 1.96 and
a false discovery rate, FDR 0.05. The Bayesian Z score analysis demonstrated that the total
number of unique differentially expressed genes changed during the MAP infectionwas nearly
the same as that in MAA, 744 compared to 617 respectively (Table 1). Between these two
groups of significant genes (inclusive of all time points), there were 106 common up regulated
genes and 35 down regulated betweenMAP and MAA inoculated intestinal tissue. There were
a fair number of genes both up regulated and down regulated in common at each time point
(Table 1). Over the whole time-course, there were several genes that were unique to either
MAP (622), or to MAA (484). The results suggest that there are significant temporal pattern
and gene expression differences between the MAP and MAA groups which may underlie the
Fig 1. Invasion of Jejunal and Jejuno-ilealMucosaby MAP andMAA.
doi:10.1371/journal.pone.0161946.g001
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persistent and transient natures of host infection, respectively. S1 and S2 Tables provide the
complete list of Bayesian Z-scored genes with associated q-values over the whole time-course
for MAP and MAA respectively.
Distinct Differences betweenMAP andMAA Infected Host Pathway and
GOCategoryPerturbationsSupport the Hypothesis of Persistence vs.
Transient Mechanisms
It is assumed that the pathways and GO differences in activation and repression over the time
course of infection provide evidence of plausible MAP/MAA host evasion and defensive mech-
anisms. Pathway and GO perturbation analysis was employed using SBCPDBGGA techniques
to characterize the host response to MAP and MAA infection. As part of the DBGGA scoring
method, the pathways, GO categories, and associated genes are scored based on the complete
gene group and individual gene contribution to the pathway/GO perturbation. The DBGGA
score is computed from the log-likelihoodmeasure of the pathogen-infected condition data fit
to the learned network model of the control (uninfected) condition as described in the S1 File.
The log likelihood is transformed to a normalized Z-score, hereafter referred to as the pathway,
GO, or individual gene DBGGAZ-score. The summary of scoring results (Table 2) of the path-
ways and GO categories indicated that bothMAP and MAA groups had early pathway pertur-
bations at 0.5 hours post infection. A comprehensive list of the significantly perturbed
activated or repressed pathways, by time point, identified for MAP and MAA inoculated loops,
with pathway DBGGA |Z-score| 2.24 threshold is provided in S3 Table and S4 Table, respec-
tively. The GODBGGAZ-score results for MAP and MAA are provided in S7 Table and S8
Table, respectively. These results are employed to identify contrasting differences and similari-
ties as presented in the next section.
Contrasting the Differences betweenMAP vs. MAAMediatedHost
Responses
The perturbedpathways and GO categories for MAP and MAA inoculated loops were rather
different on a time-point to time-point basis and there were several distinct and interesting dif-
ferences in the magnitude and state of their activation or repression. These differences can be
Table 1. Analysis of number of expressed genes changedduring theMAP andMAA infection.
Condition Total Changed Total Up/Down 0.5 hr 1 hr 2 hrs 4 hrs 8 hrs 12 hrs
MAP vs. PBS 744 560 141 37 70 20 258 66
184 16 71 30 16 54 4
MAA vs. PBS 617 400 54 15 62 4 129 150
217 27 33 16 6 82 62
Common in MAP & MAA 141 106 17 11 11 1 27 16
35 4 13 5 2 9 1
Unique in MAP 622 468 124 26 59 19 231 50
154 12 58 25 14 45 3
Unique in MAA 484 304 37 4 51 3 102 134
180 23 20 11 4 73 61
Bayesian Z-score (filtered at |zscore| 1.96) with variance smoothing, outlier removal, and false discovery rate 0.5 shows the analysis of number of
expressed genes changed during the MAP and MAA infection. Note: |z-score|> = 1.96, maximum false discovery rate at any one time point Q-value < = 0.05
(or < = 5%)
doi:10.1371/journal.pone.0161946.t001
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Table 2. DBGGAScoringSummaries for Pathways andGeneOntologies for both theMAP andMAAConditions.
Table 2(A) MAP Pathway
Time Post Innocation
MAP Pathway DBGGA Scoring 0.5 hr 1 hr 2 hrs 4 hrs 8 hrs 12 hrs Total (Unique)
DBGGA Zscore Significantly Activated 47 0 2 3 13 126 144
DBGGA Zscore Significantly Repressed 41 0 1 0 0 18 59
Total Significantly Perturbed 88 0 3 3 13 144 162
Table 2(B) MAA Pathway
Time Post Innocation
MAA Pathway DBGGAScoring 0.5 hr 1 hr 2 hrs 4 hrs 8 hrs 12 hrs Total (Unique)
DBGGA Zscore Significantly Activated 13 1 2 14 0 79 89
DBGGA Zscore Significantly Repressed 28 0 0 2 0 30 57
Total Significantly Perturbed 41 1 2 16 0 109 128
Table 2(C) MAP GOCategory Scoring Summary
Time Post Innocation
MAP GOCategoryDBGGA Scoring 0.5 hr 1 hr 2 hrs 4 hrs 8 hrs 12 hrs Total (Unique)
DBGGA Zscore Significantly Activated 682 8 81 400 766 2152 2718
DBGGA Zscore Significantly Repressed 415 2 1 15 62 384 823
Total Significantly Perturbed 1097 10 82 415 828 2536 3138
Table 2(D) MAAGOCategory Scoring Summary
Time Post Innocation
MAAGOCategoryDBGGA Scoring 0.5 hr 1 hr 2 hrs 4 hrs 8 hrs 12 hrs Total (Unique)
DBGGA Zscore Significantly Activated 194 62 375 1538 99 1451 2543
DBGGA Zscore Significantly Repressed 219 24 16 179 13 622 984
Total Significantly Perturbed 413 86 391 1717 112 2073 3001
Table 2(E) MAP Pathway Gene DBGGA Scoring Summary
Time Post Innocation
MAAGenes DBGGA Scoring 0.5 hr 1 hr 2 hrs 4 hrs 8 hrs 12 hrs Total (Unique)
DBGGA Zscore Significantly Up regulated 231 37 70 98 161 328 725
DBGGA Zscore Significantly Down regulated 253 25 48 45 64 228 591
Total Significantly Perturbed 484 62 118 143 225 556 1171
Table 2(F) MAA Pathway Gene DBGGA Scoring Summary
Time Post Innocation
MAAGenes DBGGA Scoring 0.5 hr 1 hr 2 hrs 4 hrs 8 hrs 12 hrs Total (Unique)
DBGGA Zscore Significantly Up regulated 141 64 134 193 69 270 688
DBGGA Zscore Significantly Down regulated 246 67 54 80 39 238 631
Total Significantly Perturbed 387 131 188 273 108 508 1144
Table 2(G) MAPGOGene DBGGA Scoring Summary
Time Post Innocation
MAP GOGene DBGGAScoring 0.5 hr 1 hr 2 hrs 4 hrs 8 hrs 12 hrs Total (Unique)
DBGGA Zscore Significant Up Regulated 486 60 105 155 368 765 1531
DBGGA Zscore Significant Down Regulated 463 25 31 44 67 453 1038
Total Significantly Perturbed 949 85 136 199 435 1218 2381
Table 2(H) MAAGOGene DBGGA Scoring Summary
Time Post Innocation
MAAGOGene DBGGA Scoring 0.5 hr 1 hr 2 hrs 4 hrs 8 hrs 12 hrs Total (Unique)
DBGGA Zscore Significant Up Regulated 275 119 205 388 85 606 1422
DBGGA Zscore Significant Down Regulated 517 71 55 115 30 517 1220
Total Significantly Perturbed 792 190 260 503 115 1123 2381
Summaryof significantly perturbedpathways, Gene Ontologies, and associated genes passing 97.5% confidence threshold (DBGGA |zscore| 2.24). This
table compares: (A) MAP versus PBS (uninfected) pathway scores; (B) MAA versus PBS pathway scores; (C) MAP versus PBS GeneOntology scores; (D)
MAA versus PBS Gene Ontology scores; (E) MAP versus PBS Pathway gene scores; (F) MAA versus PBS Pathway gene scores; (G) MAP versus PBS
Gene Ontology gene scores; and (H) MAA versus PBS GeneOntology gene scores.
doi:10.1371/journal.pone.0161946.t002
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observed in the pathway comparative heatmaps of Fig 2 in which the magnitude betweenMAP
vs PBS (Fig 2A and MAA vs PBS (Fig 2B) can be observed for each time point in which red
indicates pathway activation, green indicates repression, while grey indicates no significant dif-
ference. Fig 2A and 2B excluded metabolic pathways and diseases from the heatmap so that the
results can be more focused on those associated with signaling cascades and cell and membrane
interactions. It is apparent from Fig 2 and the summaries of Table 2 that bothMAP and MAA
had significant pathway perturbations at 0.5 and 12 hours post inoculation.However, in several
cases, the pathway activations for MAP are opposite to that of MAA and in several cases the
pathways are highly activated in one condition and not in the other. Fig 3 heatmap is a side-by-
Fig 2. Heatmap comparisonof significantly perturbedpathways (DBGGA |zscore| 2.24) for the (A) MAP vs PBS and (B) MAA vs PBS. Red
indicates activation and green indicates repression. The gradient in color indicatesmagnitude of perturbation(i.e., higher |zscore|).
doi:10.1371/journal.pone.0161946.g002
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side comparison (by time point) that was based on first selecting all significantly perturbed
MAP infected host pathways at 30 minutes post infection and then compared to MAA results.
Likewise for the GO categories (top scoring and immune related) shown in Fig 4, there are
striking differences in biological processes betweenMAP and MAA host response.
We focused our analysis to determine if these differencesmay lead to biologically significant
persistence or transient outcomes duringMAP/MAA infection.We compared the responses of
the host against MAP and MAA by two different approaches. First, we performed a differential
comparison of host responses based on the pathway and GODBGGA analysis duringMAP
and MAA infection. Second, we identified the common and unique mechanistic genes (genes
which contribute to perturbations in context with its interaction with other network genes or
gene sets) for these pathways/GO categories duringMAP and MAA infection.
Pathway and GODBGGAAnalyses. The temporal analysis of pathways and GO catego-
ries perturbedby MAP and MAA disclosed several similarities and some very distinct differ-
ences in the host responses. Pathways and GO categories that have either: 1) a reversed state of
activation betweenMAP and MAA host response; or 2) have unique pathway/GO perturba-
tions in comparison to the other infectious condition are hypothesized to be related to the
Fig 3. Heatmapof pathway scores of a side-by-side comparison (by time point) betweenMAP vs PBS versusMAA vs PBS. The heatmap
comparesMAP significantly perturbed pathways to theMAA condition. The selection of pathways was based on those that were found significant
(DBGGAzscore 2.24) for theMAP condition at 30 minutes post infection. Red indicates activation and green indicates repression. The gradient in
color indicates magnitude of perturbation (i.e., higher |zscore|).
doi:10.1371/journal.pone.0161946.g003
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MAP and MAA pathogenic differences.We employ the pathway DBGGA score heatmaps in
Fig 3 to provide a quick visual comparison of significantly perturbedpathways for the MAP vs
PBS and MAA vs PBS condition that focus on the early pathway activations of MAP at 30 min-
utes post infection. In general, MAP infected jejunal and jejuno-ileal tissues had more pathway
activations and of higher magnitude than MAA. Interestingly, several key pathways had
reversed states of activation and/or repression which maybe hypothesized as evidence of patho-
genic differences betweenMAP and MAA host response.
Fig 4. Heatmapof GeneOntologyscores of a side-by-side comparison (by time point) betweenMAP vs PBS versusMAA vs PBS. The heatmap
comparesMAP significantly perturbedGeneOntology categories to theMAA condition. This subset of GO categorieswere selected based on relevance
to the immune response and are top scoringGO categories found significant (DBGGAzscore 2.24) for theMAP condition at 30 minutes post infection.
Red indicates activation and green indicates repression. The gradient in color indicates magnitudeof perturbation (i.e., higher |zscore|).
doi:10.1371/journal.pone.0161946.g004
Host Gene Expression duringMAP or MAA Infection Provide Clues for Persistent or Transient Outcome
PLOSONE | DOI:10.1371/journal.pone.0161946 September 21, 2016 11 / 33
We found it advantageous to define an early stage (30 and 60 minutes post infection) and
late stage (480 and 720 minutes post infection) host immune response to assess which path-
way/GO responses may be related to the pathogen invasion/evasion (early stage) and which
may be associated with an effective or ineffective host defensive response (late stage). Table 3
(A) lists the biological processes found to have a reversed state of activation and/or repression
for pathways and GO immune categories organized by early and late stages. The pathways and
GO categories found to be unique to the MAP condition or the MAA condition are listed in
Table 3(B) and 3(C) respectively and are also organized into early and late stage responses. For
example, some of the early stage reversed pathways include the B cell receptor signaling, Focal
adhesion and Adherens junction pathways. Unique MAP pathway/GO activations include
Cytokine-cytokine receptor interaction, mTOR signaling, and Interferon-gamma-mediated
signaling pathway. Unique MAA pathway/GO activations include Regulation of actin cytoskel-
eton, Phagosome, and Regulation of T-helper 1 type immune response. Model interrogation
results for pathways listed on Table 3 are provided in S12 Table.
Several of the DBGGA scored Gene Ontology (GO) categories also identified contrasting
differences betweenMAP and MAA host response during the early stage (30–60 min.). Focus-
ing on several top scoring immune related GO categories, the MAP-MAA comparative heat-
map (Fig 4) indicates a much stronger perturbation of several GO gene sets. The MAP host
response had high activation of processes associated with regulation of interferon-beta produc-
tion, leukocyte homeostasis, chemokine biosynthetic process, and innate immune response in
mucosa. Highly repressed processes included positive regulation of endocytosis, cell-cell adhe-
sion mediated by integrin, and negative regulation of defense response to virus. Three signifi-
cant differences observedbetweenMAP and MAA response were the reversed states of the
processes of Epithelial cell proliferation, Regulation of interferon-beta production, and Regula-
tion of type 2 immune response. Such comparisons provide compelling evidence suggesting
that the virulence factors of MAP are manipulating epithelial cell proliferation, interferon pro-
duction, and immune responses immediately after MAP infection and are possibly associated
with its persistence in the host. The detailed analysis of several of the most interesting MAP/
MAA pathway and GO perturbation pathogenic differences is presented in S2 File.
The interpretation of pathway/GO pertubations, described in S2 File, suggest that MAP has a
strong influence on the mucosal barrier and cell adhesion processes. These observedresponses
suggest that the MAP host invasion may bemodulating critical cell adhesion processes in a com-
plex manner distinctly different thanMAA. Prior studies have shown that up regulation
(increased gene expression) of the junction/adhesionpathways may lead to strengthening the
intestinal mucosal barrierwhile down regulation (disrupted gene expression) may result in weak-
ening of this immune barrier. Reported previously [14], theMAP infection caused a marked
decrease in the Trans-Epithelial Resistance (TER) of an in vitromodel of polarized epithelial cells,
suggesting that increased permeability of in vivo host intestinal epitheliummay facilitate bacterial
invasion through the intestinal epithelium. The mucosal barrier has threemajor components, the
mucus layer, the epithelial glycocalyx and the surface epithelium itself, whose integrity largely
depends on Tight Junction function [24]. The Tight Junction would appear to play a major role in
the pathogenic difference between theMAP andMAA host response. As described in S2 File, we
developed a method to interrogate pathway Bayesian networkmodels to identifymechanistic
genes which takes into consideration the strength of gene-to-gene correlations and the state of
perturbation.The Tight Junction pathway was found to have several significantmechanistic genes
and gene-to-gene correlation differences as graphically illustrated in the networkmodels of Fig
5A and 5B. Detailed comparison of modeling results identified the common and most divergent
mechanistic genes as listed in Tables 4–6. The most striking candidate mechanistic relationships
that define distinctMAP/MAAdifferences are CLDN7!TJP1, CLDN7!TJP2, CLDN7!TJP3,
Host Gene Expression duringMAP or MAA Infection Provide Clues for Persistent or Transient Outcome
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Table 3. Early and Late Stage Pathway andGeneOntologies Having Reversed and uniquePerturbation States duringMAP andMAA Interaction.
Table 3(A) Early and Late Stage Pathway and Gene OntologiesHaving Reversed PerturbationStates
Early Stage Reversed States [30–60minutes post infection (p.i.)] DBGGA Zscore
MAP MAA MAP MAA
Pathways ReversedActivated or Repressed 30 min. 30 min. 60 min. 60 min.
Adherens junction -2.03 2.07 0.00 0.00
Focal adhesion -1.98 1.42 0.00 0.25
B cell receptor signaling pathway 2.31 -2.36 0.00 1.26
TGF-beta signaling pathway 2.95 -1.57 0.00 0.88
Calcium signaling pathway 3.15 -1.76 0.00 0.00
Gap junction 3.20 -2.31 0.00 -0.11
GOCategories Reversed Activated or Repressed
complement activation 2.96 -1.83 0.73 1.65
negative regulation of immune effector process 2.13 -2.07 0.00 -0.94
negative regulation of immune response 2.10 -3.45 0.76 1.08
regulation of interferon-beta production 4.58 -2.39 0.00 -2.34
regulation of type 2 immune response 2.95 -2.24 0.00 -0.45
epithelial cell proliferation -2.90 2.49 0.00 1.49
Late Stage ReversedStates (480–720minutes p.i.) DBGGA Zscore
MAP MAA MAP MAA
Pathways Activated or Repressed 480
min.
480
min.
720
min.
720
min.
Regulation of actin cytoskeleton -2.15 -0.01 3.64 -2.81
Melanogenesis 2.97 0.00 3.56 -2.93
Hematopoietic cell lineage 0.53 0.00 3.40 -2.15
Complement and coagulation cascades 1.78 0.13 3.35 -3.25
Chemokine signaling pathway -0.55 0.00 3.17 -3.32
Axon guidance 0.73 0.00 2.99 -3.52
Cytokine-cytokine receptor interaction 0.48 0.00 2.92 -2.35
Tight junction 0.94 0.48 2.89 -2.41
NOD-like receptor signaling pathway -0.62 -0.18 2.74 -2.87
Cytosolic DNA-sensing pathway 2.28 0.00 2.64 -2.43
Jak-STAT signaling pathway -0.19 0.00 2.59 -2.82
Gap junction -0.18 0.00 -1.99 2.57
B cell receptor signaling pathway -0.28 -0.38 -2.02 2.61
Phosphatidylinositol signaling system -1.62 0.00 -2.11 3.64
Osteoclast differentiation -0.37 0.33 -2.96 2.50
ErbB signaling pathway -0.28 -0.25 -2.97 2.92
Toll-like receptor signaling pathway -0.43 0.00 -3.04 2.12
RIG-I-like receptor signaling pathway 1.51 0.00 -3.13 2.68
Fc gammaR-mediated phagocytosis -1.34 -0.01 2.03 -1.95
GOCategories Reversed Activated or Repressed
phagocytosis 2.00 2.00 -2.34 3.17
chemokine biosynthetic process -2.14 0.72 3.59 -4.09
chemokine receptor activity 0.00 0.00 3.20 -1.87
complement activation -0.16 0.53 1.65 -2.43
leukocyte homeostasis 2.16 0.00 2.49 -3.36
positive regulation of defense response to virus by host 1.18 0.00 -1.92 3.06
positive regulation of humoral immune response -2.12 0.73 -3.00 3.21
positive regulation of immunoglobulin mediated immune response -1.75 0.13 -1.98 2.60
Table 3(B) Early and Late Stage Pathway and Gene OntologiesUnique to MAP Condition
Eearly Stage MAP ConditionUnique (30–60minutes p.i.) DBGGA Zscore
MAP MAA MAP MAA
Unique Pathway Activated or Repressed 30 min. 30 min. 60 min. 60 min.
Complement and coagulation cascades 3.13 1.17 0.00 0.75
(Continued)
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Table 3. (Continued)
ABC transporters 3.11 -1.06 0.00 1.00
Cytosolic DNA-sensing pathway 2.85 1.51 0.00 1.25
SNARE interactions in vesicular transport 2.83 -1.57 0.00 1.55
Cytokine-cytokine receptor interaction 2.50 0.86 0.00 0.03
Notch signaling pathway 2.32 1.40 0.00 -0.05
Hematopoietic cell lineage 2.25 1.41 0.00 -0.35
Adipocytokine signaling pathway 2.24 -0.93 0.00 0.00
mTOR signaling pathway 2.15 -0.59 0.00 -1.32
ErbB signaling pathway 2.12 -0.42 0.00 0.05
Toll-like receptor signaling pathway 2.12 1.68 0.00 1.23
Aldosterone-regulated sodium reabsorption -2.20 -1.40 0.00 -0.39
Proteasome -2.24 -1.75 0.00 -0.88
Leukocyte transendothelial migration -2.27 -1.88 0.00 0.91
Protein processing in endoplasmic reticulum -2.56 -1.90 0.00 -0.87
Vasopressin-regulated water reabsorption -2.73 -1.58 0.00 0.00
Phosphatidylinositol signaling system -2.82 -1.44 0.00 -1.00
Tight junction -2.93 -1.89 0.00 -0.67
GOUnique Activation and Repression
interferon-gamma-mediated signaling pathway 3.25 -1.46 0.00 1.39
innate immune response in mucosa 3.56 0.00 0.00 0.00
antibacterial humoral response 3.52 1.86 0.34 -0.75
regulation of immunoglobulin mediated immune response 3.16 1.64 -0.22 1.65
neutrophil mediated immunity 3.07 -1.09 0.00 0.89
adaptive immune response 3.01 1.00 0.86 1.31
complement activation 2.96 -1.83 0.73 1.65
positive regulation of defense response to virus by host 2.92 1.64 -0.24 1.66
myeloid leukocyte mediated immunity 2.65 -0.97 0.00 -0.40
chemokine receptor activity 2.62 -0.53 0.00 -0.72
positive regulation of innate immune response 2.31 0.22 0.00 -0.14
leukocyte mediated immunity 2.29 -0.62 0.00 -0.42
complement activation, classical pathway 2.22 -1.29 1.02 1.84
T cell mediated immunity 2.18 1.35 -0.85 -0.31
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains 2.14 0.83 -0.17 0.62
regulation of adaptive immune response 2.14 1.36 -0.52 -0.19
chemokine biosynthetic process 2.13 1.18 0.00 2.28
cell-cell adhesion mediated by integrin -2.43 1.58 0.00 0.00
Late Stage MAP ConditionUnique (480–720minutes p.i.) DBGGA Zscore
MAP MAA MAP MAA
Unique Pathway Activated or Repressed 480
min.
480
min.
720
min.
720
min.
ECM-receptor interaction 1.97 0.00 3.17 -1.72
Vasopressin-regulated water reabsorption 2.66 0.00 2.82 1.89
Progesterone-mediated oocyte maturation 0.64 0.00 2.73 1.89
Proximal tubule bicarbonate reclamation 1.05 0.00 2.71 1.62
Cell adhesion molecules (CAMs) 1.22 0.00 2.60 1.83
ABC transporters 0.95 0.00 2.27 1.76
Renin-angiotensin system -0.58 0.00 -2.03 -0.09
mTOR signaling pathway 1.07 -0.32 -3.20 -1.92
GOUnique Activation and Repression
chemokine receptor activity 0.00 0.00 3.20 -1.87
phagocytosis, engulfment 0.00 0.00 3.04 -1.74
negative regulation of immune effector process 0.84 0.00 3.04 1.19
immune response-regulating cell surface receptor signaling pathway 0.00 -0.96 2.59 1.67
(Continued)
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CDK4!CSDA, ACTB!MYL2, ACTG1!MYL2, ACTN1!MAGI3, CLDN7!MPDZ,
CLDN7!INADL, JAM3!TJP1, and ACTN3!MAGI3 (where!interaction/association).
Althoughwe identify these differences in more detail in S2 File, an important example is the
strong down regulation of CLDN7 (claudin 7) by MAP. CLDN7 encodes an integral membrane
Table 3. (Continued)
innate immune response 1.75 0.00 2.51 1.91
negative regulation of immune response -1.49 -0.37 2.42 1.46
lymphocyte activation involved in immune response 1.48 0.00 2.36 0.72
regulation of type 2 immune response 0.00 0.00 2.32 1.57
myeloid cell activation involved in immune response -0.60 0.24 2.23 1.94
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains 0.00 0.00 2.18 1.72
natural killer cell mediated immunity 0.59 0.00 -2.00 1.06
MyD88-dependent toll-like receptor signaling pathway 0.86 0.00 -2.03 1.09
regulation of T-helper 1 type immune response 0.00 0.00 -2.40 1.55
neutrophil mediated immunity 2.07 0.00 -2.94 -1.37
humoral immune response mediated by circulating immunoglobulin 2.10 0.38 -3.46 1.23
Table 3(C) Early and Late Stage Pathway and Gene OntologiesUnique to MAA Condition
Eearly Stage MAA ConditionUnique (30–60minutes p.i.*) DBGGA Zscore
MAA MAP MAA MAP
Unique Pathway Activated or Repressed 30 min. 30 min. 60 min. 60 min.
Regulation of actin cytoskeleton 2.26 -1.84 0.53 0.00
Neuroactive ligand-receptor interaction 2.04 1.83 0.33 0.00
VEGF signaling pathway -1.96 1.51 1.18 0.00
Fc epsilon RI signaling pathway -2.06 1.27 1.28 0.00
Phagosome -2.53 -1.88 0.19 0.00
Antigen processing and presentation -2.14 1.65 -0.57 0.00
GOUnique Activation and Repression
cytokine production involved in immune response 3.14 1.86 -1.30 -0.20
regulation of innate immune response 2.50 1.81 1.53 0.00
regulation of T-helper 1 type immune response 2.18 1.49 -0.61 -0.77
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily
domains
2.10 1.71 -0.48 -0.52
type 2 immune response -2.26 1.11 -0.35 0.00
T cell costimulation 2.33 0.05 -0.78 0.00
interleukin-12 production 2.19 1.55 1.19 0.00
negative regulation of JAK-STAT cascade -2.95 -1.21 -0.23 -0.22
Late Stage MAA ConditionUnique (480–720minutes p.i.*) DBGGA Zscore
Unique Pathway Activated or Repressed MAA MAP MAA MAP
480
min.
480
min.
720
min.
720
min.
Fc epsilon RI signaling pathway -0.70 0.00 2.55 -1.60
p53 signaling pathway 0.00 -0.09 2.46 -1.67
Notch signaling pathway 0.00 -0.75 -2.67 -1.67
GOUnique Activation and Repression
positive regulation of production of molecular mediator of immune response -0.41 0.00 3.00 0.63
regulation of cytokine production involved in immune response -0.24 -0.64 2.28 1.63
immune effector process 0.00 -0.34 1.98 0.93
positive regulation of myeloid leukocyte cytokine production involved in immune response 0.00 1.02 -2.25 1.31
(A) Pathways and GO immune categories showing a reversal in states of activation or repression betweenMAP andMAA condition and separated by early
and late stages. (B) The pathways and GO categories found to be unique to the MAP condition. (C) The pathways and GO categories found to be unique to
the MAA condition separated into early and late stages.
doi:10.1371/journal.pone.0161946.t003
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protein and component of the tight junction strands that serve as a physical barrier to prevent sol-
utes and water from passing freely through the paracellular space between epithelial or endothelial
cell sheets. Prior research showed that CLDN7 deficientmice severely disrupted the integrity of
the mucosal/epithelial barrier [25]. Interestingly, in the late stage, the Tight Junction pathway for
theMAP condition becomes strongly activated. In contrast, theMAA early stage Tight Junction
pathway host response was not significantly perturbed, suggesting that MAAmay not be as effi-
cient as MAP to cross the epithelial barrier. Unexpectedly, by the late stage, theMAA condition
Tight Junction perturbation did become significantly repressed (Table 3(A) late stage). The junc-
tion and cell adhesion related mechanistic gene DBGGAZ-scores are shown in theMAP-MAA
comparative heatmap of Fig 6A. In the early stage (30 minutes post infection),MAP has a higher
number of significant down regulated genes in comparison toMAA.While in the late stage most
junction/adhesion related genes are less expressive in both conditions.
The Gene Ontology (GO) term “cell-cell adhesion mediated by integrin” was also signifi-
cantly repressed at the early stage for the MAP condition. Cell adhesion serves to facilitate traf-
ficking and migration of T lymphocytes into sites of inflammation, movement of lymphocytes
within the rich environment found in extravascular tissue, and the physical interaction between
antigen-reactive T cells and antigen-presenting cells that is required for efficient T-cell activa-
tion [26]. The repressed junction/adhesion related pathways and their associated genes suggest
that MAPmay disrupt T lymphocyte recruitment, which helps explain the lack of chronic
inflammation observed in the MAP infected ileal loops and may further subvert mucosal heal-
ing [14]. It has been proposed by others [27] that a bacterial survivalmechanism in mucosal
epithelial cells is for the bacteria to hijack integrin-linked kinase to stabilize focal adhesions
and block cell detachment of infected cells. The rapid turnover and exfoliation of mucosal epi-
thelial cells provides an innate defense system against bacterial infection. The significant
repression and reversed state of the GO category, “Epithelial cell proliferation”, (Table 3(A)
early stage) provides evidence of MAP interference with this important host defensive process
and suggests that bacteria such as MAPmay be able to subvert this immune defense mecha-
nism and colonize the epitheliummore efficiently to survive. Furthermore, for MAA, the GO
category “Epithelial cell proliferation”, host response was strongly activated, suggesting a
strengthening of the mucosal/epithelial barrier and perhaps decreasing the efficiencyof MAA
invasion. Fig 6(B) shows a heatmap of the DBGGA gene scores for the Epithelial cell prolifera-
tion gene set. At 30 minutes post infection, the MAP condition shows both strong down and
up regulation of genes in comparison to the low expression values in MAA.
The Toll-like receptor pathway was strongly activated in MAP but only modestly activated
inMAA in the early stage. For theMAP condition, the early stage pathway activation was dom-
inated by TLR3 up regulation, but this becomes insignificantly expressed in the late stage.
Interestingly, in the MAA condition, TLR3 was only significantly up regulated at 240 minutes
post infection perhaps suggesting a delayed TLR response. However, for the MAA early stage
condition, TLR9 was significantly up regulated, but insignificant in the late stage. In contrast,
TLR9 was not expressed in the MAP condition until it became significantly down regulated in
the late stage (720 minutes post infection). Interestingly, TLR2, TLR4, TLR5 and TLR6 were
not significantly expressed in either condition, but the gene CD14, which acts as a co-receptor
with TLR4 for the detection of bacterial lipopolysaccharide (LPS) was significantly expressed
in bothMAP and MAA infected hosts (early stage) and became insignificantly expressed in the
Fig 5. (A) TheMAP-MAA condition comparison of the Tight Junction pathway Bayesian models with the state of gene expression and
mechanistic genes shown for the 30 min post infection time point. (A) The sameMAP-MAA condition comparison with the state of gene
expression andmechanistic genes shown for the 30min post infection time point. The legend indicates themeaning of node colors
(representing a gene expression level) and arcs between connecting genes.
doi:10.1371/journal.pone.0161946.g005
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late stage. Numerous mycobacterial studies have revealed that TLR2 is involved in innate rec-
ognition and responses in the innate immune cells [28], which appears to be contradictory to
that found in this in vivo study in which TLR3 and TLR9 were the only significantly up regu-
lated TLRs for MAP and MAA respectively.
Table 4. CommonMAP andMAAArcs andMechanistic Genes in Tight JunctionPathway.
Parent
Gene
Parent Gene
Description
Child
cause
Childgene MAP
Norm.
Arc Wt.
MAA
Norm.
Arc Wt.
Abs. Val.
Difference
Correl.
Direction
MAP 1st
Mechanistic
Time
MAP
Parent
Gene
Score
MAP
Child
Gene
Score
MAA 1st
Mechanistic
Time
MAA
Parent
Gene
Score
MAA
Child
Gene
Score
PARD3 par-3
partitioning
defective 3
homolog (C.
elegans)
JAM3 junctional
adhesion
molecule 3
0.27 0.56 0.29 positive t = 30 0 2.62 t = 720 -2.9 0
ACTB actin, beta MYL12A myosin, light
chain 12A,
regulatory,
non-
sarcomeric
0.2 0.38 0.18 positive t = 720 0 2.12 t = 30 -3.72 0
CLDN7 claudin 7 MPDZ multiple PDZ
domain
protein
-0.42 -0.2 0.33 negative t = 60 -3.17 0 T = 480 2.4 0.81
TJP1 tight junction
protein 1
ACTG1 actin, gamma
1
0.39 0.26 0.13 positive t = 60 0 2.04 t = 60 0.74 2.57
ACTG1 actin, gamma
1
MYH9 myosin,
heavy chain
9, non-muscle
0.56 0.45 0.11 positive t = 60 2.04 -1.37 t = 60 2.57 -1.55
CDC42 cell division
cycle 42 (GTP
binding
protein,
25kDa)
PARD6B par-6
partitioning
defective 6
homolog beta
(C. elegans)
0.74 0.44 0.3 positive t = 720 -3.53 -0.81 t = 240 2.53 0
CLDN7 claudin 7 TJP3 tight junction
protein 3
(zona
occludens 3)
0.6 0.23 0.37 positive t = 60 -3.17 -1.81 t = 480 2.4 0
CDK4 cyclin-
dependent
kinase 4
CSDA cold shock
domain
protein A
-0.36 -0.2 0.16 negative t = 30 -2.37 -0.11 t = 240 0 -2.7
CSNK2B casein kinase
2, beta
polypeptide
no child
node
0 0 0 positive t = 30 -4.07 0 t = 30 -2.94 0
CTNNA1 catenin
(cadherin-
associated
protein), alpha
1, 102kDa
no child
node
0 00 positive t = 30 -2.27 0 t = 240 2.06 0
AKT2 v-akt murine
thymoma viral
oncogene
homolog 2
no child
node
0 0 0 positive t = 60 2.08 0 t = 720 2.47 0
PRKCZ protein kinase
C, zeta
no child
node
0 0 0 positive t = 240 2.72 0 t = 30 -2.75 0
EPB41L1 erythrocyte
membrane
protein band
4.1-like 1
no child
node
0 0 0 positive t = 30 2.03 0 t = 240 -2.36 0
Tight Junction Pathway Bayesian Model Interrogation Results of Gene-to-Gene Relationships and Mechanistic Genes found in common between the MAP
andMAA conditions. See text for description of interrogation methods.
doi:10.1371/journal.pone.0161946.t004
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TLR3 (up regulated in MAP) plays a fundamental role in pathogen recognition and should
mediate the production of proinflammatory cytokines necessary for the development of an
effective immune response. TLR3 activation should be inducing the activation of IRF3 which,
in turn, should induce the production of type I interferons (IFNs). However, IRF3 was signifi-
cantly down regulated in bothMAP and MAA conditions in the early stage and there was
insignificant expression of any type I IFNs or type II IFNs. Moreover, the GO categories for
Regulation of interferon-beta (IFN-β) and Interferon-gamma (IFN-γ)-mediated signaling were
significantly activated in MAP condition, but were both repressed in the MAA condition.
Interestingly, in the MAP condition (early and late stage), the chemokine CXCL9 is up regu-
lated, but down regulated in MAA condition (early stage). CXCL9 is known to be a T-cell che-
moattractant that is normally induced by IFN-γ. However, the MAP infected host did have
several up regulated cytokines that included IL1β, IL4, CCL25, CX3CL1, CCL20, IL7, IL18,
CXCL9, and IL10 primarily all during the late stage. Interestingly, some of these cytokines are
predicted to be regulators of immune outcome during mathematical modeling of MAP infec-
tion, and also regulators of infection outcomes in clinical cases in mycobacterial disease [29–
31].
TLR9 (up regulated in MAA only) is preferentially expressed in immune cell rich tissues
from cells such as B lymphocytes, monocytes, natural killer (NK) cells, and plasmacytoid den-
dritic cells. TLR9 is activated by microbial DNA containing unmethylated CpGmotifs. MAP is
proposed to evade host immunity by altering the TLR9 signaling [31]. TLR9 signals lead to the
activation of cells initiating pro-inflammatory reactions in the production of cytokines such as
type-I interferon and IL-12. Interestingly, IFN-βwas insignificantly expressed in the MAA
infected host, but the GO category “Regulation of cytokine production involved in immune
response” was significantly activated suggestingMAA was activating some cytokine response.
However, the only cytokines significantly up regulated in the MAA infected host were TNF,
CCL5, IL18, IL5, IL12β, IL4, and CXCL9. TNF is associated with apoptosis. In both the MAP
and MAA infected host, there was activation of apoptosis only in the late stage. CCL5 plays an
active role in recruiting leukocytes into inflammatory sites. IL5 stimulates B cell growth and
Table 6. UniqueMAAArcs andMechanistic Genes in Tight JunctionPathway.
Parent
Gene
Parent Gene
Description
Child
Gene
Child Gene
Description
MAANorm.
Arc Wt.
MAA
Norm.
Arc Wt.
Abs. Val.
Difference
Correl.
Direction
MAA 1st
Mechanistic
Time
MAA
Parent
Gene
Score
MAA
Child
Gene
Score
MAP 1st
Mechanistic
Time
MAP
parent
Gene
Score
MAA
Child
Gene
Score
ACTB actin, beta MYL7 myosin, light
chain 7,
regulatory
0.23 -0.01 0.24 reverse t = 30 -3.72 0 t = 720 0 2.11
ACTG1 actin,
gamma 1
TJP2 tight junction
protein 2
(zona
occludens 2)
-0.45 -0.17 0.28 negative t = 30 0.03 2.02 t = 60 2.04 0
ACTB actin, beta MYH14 myosin, heavy
chain 14, non-
muscle
0.28 0.16 0.12 positive t = 30 -3.72 0 0 0
ACTB actin, beta MYH9 myosin, heavy
chain 9, non-
muscle
0.58 0.42 0.16 negative t = 30 -3.72 0 0 0
ACTB actin, beta MYH1 myosin, heavy
chain 1,
skeletal
muscle, adult
-0.29 -0.44 0.15 negative t = 30 -3.72 0 0 0
Tight Junction Pathway Bayesian Model Interrogation Results found unique to the MAA condition.
doi:10.1371/journal.pone.0161946.t006
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increases immunoglobulin secretion. IL18 together with IL-12 induces cell-mediated immunity
following infection and exposure to microbial products like LPS. TLR9 has been reported to be
essential for the efficient control of MAA infection, however it could be independent of Th1
type cytokine induction [31]. S13 Table shows the Bayesian model interrogation results of
gene-to-gene relationships and Mechanistic genes for Toll-like Receptor Pathway for genes
common between the MAP and MAA conditions (A), unique to the MAP condition (B), and
unique to the MAA condition (C).
Interestingly, it has been reported in some studies that mycobacterial evasionmay involve
increased secretion of IL10 rather than IL12 by dendritic cells. Secretion of IL10 will favor the
activation of a Th2 response which is incapable of destroying intracellular pathogens. The
MAP infected host did, in fact, have increased IL10 expression and strong activation of the GO
category “Regulation of type 2 immune response” and the strong repression of the category
“Regulation of T-helper 1 type immune response”, whereasMAA favored IL12B expression
combined with the activation of the “Regulation of T-helper 1 type immune response” and the
repression of “Type 2 immune response”. Another speculatedmycobacterial evasionmethod
involves the stimulation of antigen presenting cells with mycobacterial lipoprotein that results
in decreasedmajor histocompatibility class II complex (MHCII) expression [32] where MHCII
molecules are critical for the initiation of the antigen-specific immune response. In the MAP
infected host, the MHCII gene BOLA-DMA was significantly down regulated while in the
MAA infected host, the MHCII gene HLA-DOA was significantly up regulated.MHCII gene
upregulation has been correlated with the production of TNF and IL12 that may lead to con-
tainment of MAA infection [33].
Mycobacteria are usually internalized by macrophages via phagocytosis and reside in pha-
gosomes to help escape destruction reportedly by inhibiting phagosome/lysosomematuration.
For the MAP infected host, the DBGGA analysis found the GO category “Phagocytosis” to be
activated briefly at 240 minutes post infection but becoming significantly repressed in the late
stage, while in the MAA infected host it remained strongly activated. Examining the mechanis-
tic genes of “Phagocytosis”, the main differences are significant up regulation of HMGB1,
CORO1A, and CSK for the MAA infected host, early stage, while in the late stage the dominant
genes that induced the repressed state of “Phagocytosis” for MAP condition were PIP5K1C,
HMGB1, and CORO1A. The gene PIP5K1C encodes the protein, phosphatidylinositol 4-phos-
phate 5-kinase type-1 gamma involved in a number of cellular functions, but most relevant is
that PIP5K1A is required for the regulation of actin remodeling in phagocytosis. The role of
actin cytoskeleton remodeling during particle internalization is well established, but its role
during the later stages of phagosomematuration (phagosome/lysosome fusion) remains largely
unknown. The disruption of this gene may be involved in the MAP pathogenicity by impeding
phagolysosomal fusion and hence, inhibiting phagosomematuration. Further, the repressed
state of the “phosphatidylinositol signaling system” in the MAP condition (early stage) pro-
vides additional evidence that MAPmay disrupt this process.
Our detailed analysis (S2 File) suggests that the MAA infected host response appears to be
mounting a stronger cell mediated immune response as evident by the significant activations of
the B cell receptor signaling pathway and the GO categories “Regulation of T-helper 1 type
immune response”, “Regulation of adaptive immune response”, “Cytokine production involved
in immune response”, “Regulation of innate immune response”, “T cell costimulation”, and
Fig 6. (A) Heatmap of MAP andMAA condition comparisonof DBGGA zscores for mechanistic genes in the Gap
Junction, Adherens Junction, Tight Junction, and Focal Adhesion junction pathways. (B) HeatmapMAP andMAA
condition comparison of DBGGA zscores for mechanistic genes in the GeneOntology category “Epithelial cell
proliferation”.
doi:10.1371/journal.pone.0161946.g006
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“IL12 production”. The overall number of unique pathway and GO category perturbations,
however, are far less in the MAA condition which supports the observation that MAA is not as
pathogenic as MAP. Interestingly, there are a large number of strongly perturbedpathways
and GO categories that show significant reversal of activation states betweenMAA and MAP.
For example, at the late stage, the MAA condition has 16 pathways and GO categories that
become strongly repressed in comparison to the 16 activated pathway states for MAP (Table 3
(A)), suggesting that the host may be struggling to stop the proliferation of MAP while for
MAA, the immune response may be shutting down as the host clears the MAA bacteria.
Discovery of Unique and CommonMechanisticGenes duringMAP and
MAA Infection
Pathway and GODBGGA analysis provided a list of mechanistic genes over the time course of
the MAP and/or MAA infection. A mechanistic gene is found based on how much the gene
contributes to the perturbation of the pathway and/or GO term gene set. For pathways, the
contribution is determined in the context of the network and the gene’s relationships to other
genes in the pathway Bayesian network structure (S1 File). The GOmechanistic genes are
determined by the contribution of the perturbedgene as part of the overall GO gene set mod-
eled as a naïve Bayesian net which differs from the pathway analysis by not taking into consid-
eration any network structure relationships. For the pathway analysis, S5 and S6 Tables lists
the associatedmechanistic genes filtered having a gene DBGGA |Z-score| 2.24 for the MAP
and MAA conditions, respectively. The GO gene DBGGAZ-Scores are provided in S9 and S10
Tables for the MAP and MAA conditions respectively.
For each of the significantly perturbedpathways and GO categories listed in Table 3, we
determinedwhich mechanistic genes were in common between the MAP and MAA conditions
and which were unique at both the early and late stage post infection. The results of this com-
parative analysis are illustrated in the Venn diagrams of Fig 7 with details provided in S11
Table. We found that MAP and MAA conditions had 127 perturbedmechanistic genes in com-
mon in the early stage, whileMAP had 280 uniquely perturbedmechanistic genes and MAA
had 206. As the course of infection transitioned to the late stage, there were 182 genes in com-
mon, whileMAP had 319 and MAA had 239 uniquely perturbed.The transition from early to
late stage retained only a small percentage of the same genes which suggests that the host
immune response patterns diverge considerably between conditions and over time. Interest-
ingly, some of the pathways with the highest number of mechanistic genes in common between
MAP and MAA condition during the early stage were ECM-receptor interactions, Hematopoi-
etic cell linage, Tight junction, Phagosome, Toll-like receptor signaling, RIG-I-like receptor sig-
naling, and Chemokine signaling, along with the GO terms Epithelial cell proliferation and
MyD88-dependent toll-like receptor. In the late stage, the pathways having the highest number
of mechanistic genes in common included such pathways as Cell adhesionmolecules, Cyto-
kine-cytokine receptor interactions, Fc gamma R-mediated phagocytosis, Jak-STAT signaling,
Phosphatidylinositol signaling system, Axon guidance, Adipocytokine signaling, and ErbB sig-
naling pathway, along with the GO terms Innate immune response in mucosa, T cell co-stimu-
lation, and Interferon-gamma-mediated signaling. Probably the most interesting pathways that
were found unique to MAP condition during the early stage having the highest number of
mechanistic genes included ABC transporters, ECM-receptor interaction, and Tight junction
whereas in the MAA condition the early stage pathways with higher numbers of mechanistic
genes were Gap junction, Phagosome, Axon guidance, and Fc epsilon RI signaling pathway. In
the late stage, the pathways that had the highest number of mechanistic genes in the MAP con-
dition included such pathways as Hematopoietic cell lineage, Calcium signaling, SNARE
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interactions in vesicular transport, Toll-like receptor signaling,mTOR signaling, and Epithelial
cell proliferation whereas in the MAA condition the interesting pathways included Gap junc-
tion, Notch signaling, Leukocyte transendothelial migration, Adipocytokine signaling, VEGF
signaling, and Adherens junction. These results reveal that perturbation of genes and cellular
pathways duringMAP infection was focused on host evasion facilitating persistent infection.
However, MAA infection resulted in the activation of molecular pathways that are involved
with containment of infection and resulting in transient infection.
Discussion
A key role of intestinal mucosal epithelium is barrier function, which prevents colonization or
invasion of the host by foreign microorganisms. Transmission of MAP or MAA in young
calves usually occurs via feeding on milk contaminated with these pathogens. The bacterium is
also shed in the feces; therefore fecal-oral route is another mode of transmission. Here, in this
study, ileal loop were directly inoculatedwith MAP or MAA to dissect the changes in the tran-
scription of genes in the intestinal mucosa. Intestinal transcription responses usually do not
alter much due to the presence of commensal microbiota. However, when pathogens come in
contact with the epithelial surface of the ileal mucosa, there is a change in the host gene expres-
sion. The alteration in the host gene expression may depend on the type of pathogen, pathoge-
nicity, virulence factors, and replication rate of the pathogen among several other factors. The
pathogenesis of MAP infection in ruminants and other species shows typical Th1/Th2 type of
immune profile [34–37]. Recently, a study showed that the histopathology of the cutaneous
Fig 7. Venn diagramcomparison of the number of uniqueand commonmechanistic genes found for theMAP andMAA conditions.
Only the mechanistic genes from the pathways and GO terms listed in Table 3 were used in creating this diagram.
doi:10.1371/journal.pone.0161946.g007
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delayed type hypersensitivity response were almost similar as the stage of intestinal pathology
of MAP infection [38]. Moreover, this also matched well with the systemic humoral and cellu-
lar immunity. Strong gut-associated immune responses participate in the elimination of patho-
genic microorganisms, while immune tolerance prevents harmful reactions against the gut
flora and food antigens. We have utilized the neonatal calf ligated jejuno-ileal loop model to
study the sequential changes in the host intestine after infectionwith MAP and MAA. In the
ligated ileal loop model, one can only humanely conduct the experiment for about 12 hours
under general anesthesia. Thus, we did not attempt to go beyond this time period. There could
be concerns that concentration of bacteria used in this study to inoculate ileal loop is higher
than the estimated concentration of MAP in natural conditions, in the farms, where lower con-
centrations of MAP are able to start an infection.However, the initial infection dose is undeter-
mined under farm environmental conditions, and may require more time to establish an
infection. Earlier studies have shown that animals orally inoculatedwith 5×109 CFU given on 2
consecutive days were able to establish infection [39]. Though, we inoculated 3x109 CFU, the
invasion rate of the MAP was very low (results of our invasion of bacteria in the mucosa).
Moreover, in our study the aim was to test the acute dose responses during the early establish-
ment phase of infection.One would expect very similar host gene expression responses when
genetically similar pathogens are introduced to a host species, however this prediction was not
true in the case of MAP vs. MAA enteric infection of cattle. Though the pathogens are>95%
genetically similar, MAP causes a severe chronic granulomatous enteritis in cattle, whereas
MAA infection is normally rapidly cleared [40]. Thus, the most important differences in the
MAP and MAA pathogenesis are a chronic persistent infection vs transient infection respec-
tively. The type of immune response triggered by these two very similar pathogens appears to
depend, in part, on initial recognition by the innate immune system. Our results indicate that
MAP causes a rapid and early perturbation of cellular components. This perturbation results in
dysfunction or dysregulation of the innate immune system in comparison to MAA.When this
concept is applied to natural infection with MAP, a chronic activation of innate immunity may
negatively affect adaptive immune responses, contributing to a persistent infection.However,
the components of the immune response are only partially dysfunctional duringMAA infec-
tion and thus may lead to a transient infectionwith an outcome of clearance of infection.
In a recent study published by our group, the early host response was evident by the pres-
ence of MAP infectedM cells and goblet cells [13]. M cells are unique among cells of the intes-
tinal epithelium as they display a high density of ß1 integrins on their luminal surface.
Integrins have affinity for the fibronectin attachment protein of mycobacteria.M cells facilitate
the entry of MAP into the jejuno-ilealmucosa by forming the fibronectin bridge with host
integrins [41]. Though the genes ITGß2, ITGß5, ITGA2, ITGAE, and ITGAM encoding integ-
rins were up regulated duringMAP, the integrins ITGß1 and ITGα9 were strongly down regu-
lated. ITGß2 was significantly up regulated in the MAA infection. The expression level of
ITGß2 was considerably higher in MAA infection, but MAP had two different types of down
regulated integrin expression. Junctions (tight, gap and adherens) between the epithelial cells
provide a mechanical barrier to the entry of infectious agents. MAP and MAAmay gain entry
due to the down regulation of the gene encoding tight junction protein. However, once inside
the host mucosa, mycobacteria may up-regulate the tight junction related genes (Rho GTPase
activating protein 10) that are involved in GTPase activation, actin remodeling and intracellu-
lar transport [42] necessary for alpha-catenin recruitment at adherens junctions and for inva-
sion of pathogens [43]. The increased expression of these tight junction-related genes could be
a reason for no increase in the invasion of MAP or MAA with the time of contact post
infection.
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Another important aspect of the innate response to infection is the interaction of pattern-
recognition receptors (PRRs) including TLRs with PAMP molecules. Different types of leuko-
cytes in the intestinal mucosa, i.e. dendritic cells, macrophages, eosinophils, mast cells, and nat-
ural killer cells, are localized adjacent to epithelial cells and interact with each other to
maintain homeostasis [44, 45]. Our data analysis suggests that MAPmay alert the host
immune system by interacting with TLR3 and CD14 which are expressed on the cell surface of
enterocytes and numerous cells of the immune system such as dendritic cells, B lymphocytes
and NK cells. These interactions activate several signals initiating pro-inflammatory reactions
that result in the production of cytokines such as IL1ß, IL4, CCL25, CX3CL1, CCL20, IL7,
IL18, CXCL9, and IL10. The outcome of this interaction leads to the recruitment of leukocytes
as target for intracellular replication to the site of infection. In contrast, MAA appears to inter-
act with TLR9 binding with the intracellular TLR9 receptor inside the mast cells [46]. Apart
from being a mode of entry to the host cells this interactionmay also lead to cytotoxic T cell
modulation as well as generation of pro-inflammatorymediators [46, 47]. The importance of
innate immunity has been underscored by the studies involving mycobacterial pathogens. Our
study clearly indicates that the host response starts immediately after sensing the microbial
interaction with the intestinal mucosa that in turn releases signals to stimulate recruitment of
pro-inflammatory leukocytes, immune cells, or both. Interactions betweenCD40 receptors on
macrophages and CD154 (CD40L) on activated T cells are crucial for maintaining a Th1
response and activation of macrophages [48]. However, we foundMAP favoring a bias toward
a Th2 response whereas MAA was favoring the Th1 response. Thus, MAP apparently dampens
the innate responses by affecting T cell as well as B cell activation soon after entering the host
intestinal mucosa.
DuringMAP infection, the antigen receptors of T cells are stimulated; however, due to the
apparent lack of co-stimulator molecules from APCs, further T cell activation apparently does
not occur, leading to a quasi-anergic state. Interestingly, duringMAA infection delivery of the
second signal by the APC rescues the activated T cell from anergy, allowing it to produce the
chemokines and cytokines necessary for the growth of additional T cells. These chemokines
play important roles in the development, homeostasis, and function of the immune system.
The inversely expressed (up vs. down) mechanistic genes also may predict the outcome of
the MAP and MAA infection. The ATP binding cassette was mechanistic in bothMAP and
MAA infections, however the subfamilies to which they belong were somewhat overlapping in
MAP and MAA. In the MAP infected tissues, the ATP binding cassette subfamily B,member
10,ATP binding cassette subfamily B,member 4, ATP binding cassette subfamily A,member 3,
ATP binding cassette subfamily C,member 6, ATP binding cassette subfamily A,member 1 and
ATP binding cassette subfamily D,member 3 were mechanistic, whereas in MAA infectionATP
binding cassette subfamily B,member 4,ATP binding cassette subfamily B,member 6,ATP bind-
ing cassette subfamily C,member 10,ATP binding cassette subfamily D,member 3 were mecha-
nistic. The ATP binding cassette family of genes is involved in transmembrane movement of
substances as well as transportation of cholesterol and lipids [49]. Activation of ATP binding
cassette subfamily D in MAP during the early infection probably performs very important roles
during establishment of host–pathogen interactions. In the early phase, ATP binding cassette
subfamily Dmay act via host cell signaling for pathogen recognition, invasion and intracellular
trafficking.During the infection establishment phase, it may play several immunomodulatory
roles. During pathogen replication and persistence phases, lipid metabolism has a housekeep-
ing role in energy homeostasis and biomembrane synthesis. Recently more emphasis has been
given on the host-derived lipids in mucosal defense [50, 51]. A correlation has been shown
between activation of peroxisome and mast cell maturation in allergic diseases [52].
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Calcium signaling was uniquely perturbed in the MAP infected host. The dominant mecha-
nistic genes CALM, CAMK2A,CAMK2D, and CALML5 are calcium signalingmolecules and
prominent kinases in the central nervous system that may function in long-term potentiation
and neurotransmitter release. These genes have been shown to be early responsive genes in epi-
thelial cells [53, 54].
Chemokine ligand 5 (CCL5) and its receptor Chemokine receptor 4 (CCR4) were inversely
correlated duringMAP and MAA infection (up regulated in MAP, down regulated in MAA)
but at different time points. CCL5 is chemotactic for T cells, eosinophils, and basophils, and
plays an active role in recruiting leukocytes into inflammatory sites. Secreted frizzed-related
protein 2, a mechanistic gene in MAP infection with its higher expression, may induce cellular
regulation of apoptosis and eosinophilia [55]. The expression of these genes further supports
our earlier study where we showed that the MAP infection results in the recruitment of mono-
nuclear cells to the site of infection [13]. Usually with the help of IL-2 released by T cells, CCL5
induces the proliferation and activation of certain natural-killer cells to form CC-Chemokine-
activated killer cells. However, duringMAP infection, IL-2 expression was down regulated in
the late stage, which could be a reason for the absence of CC-Chemokine-activated killer cells
duringmycobacterial infection [56, 57]. Several genes that play significant roles in T cell or B
cell activation were mechanistic duringMAP infection (CD37,CXCL9 and CXCL11). Another
mechanistic gene duringMAP infectionwas IKBKG protein (inhibitor of kappa light polypep-
tide gene enhancer in B cells), that interacts with two enzymes, IKK-alpha and IKK-beta, to
activate nuclear factorkappa-B (NFKB). In contrast, theNFKB complex is inhibited by I-
kappa-B proteins (NFKBIB) which is a mechanistic gene expressed duringMAP infection early
stage at 30 minutes post infection and was not expressed thereafter. NFKBIB inactivatesNFKB
by trapping it in the cytoplasm. Another proinflammatorymolecule, SERPINE 1, was also a
mechanistic gene in the MAP infectionmucosal tissue. Thus, early stage activation of NFKB
and SERPINE 1 in MAP infectionmay lead to the conditions for establishing chronic infection,
whereas duringMAA infection,NFKB and SERPINE 1 are inactivated and thus do not contrib-
ute to persistent inflammation.
In contrast to MAP infection, duringMAA infectionmost of the mechanistic genes played
role(s) in a protective immune response. Nuclear factor of activated T-cells (NFATC1) is a
component of the DNA-binding transcription complex. Proteins belonging to this family of
transcription factors have a central role in inducible gene transcription during the immune
response.NFATC1 is a mechanistic gene which was up regulated in the late stage duringMAA
infection, but not in MAP. It may not only provide an effective immune response by inducible
expression of cytokine genes, activation and proliferation of T cells, but it also has a role in the
differentiation and programmed death of T-lymphocytes as well as lymphoid and non-lym-
phoid cells that are involved in the capture and killing of organisms.
MAA infection perturbed the Fc epsilon RI signaling pathway soon after infection (Table 3
(C)) but this pathway was not perturbed in MAP infection. Fc epsilon RI signaling is exclusive
to mast cells. Mast cell driven immune responses are also linked with the activation of
NFATC1. Activation of mast cells triggers the release of several activated molecules such as bio-
genic amines (histamines), proteoglycans (heparin), lipid mediators such as leukotrienes
(LTC4, LTD4 and LTE4), prostaglandins (especially PGD2) and secretion of cytokines, the
most important of which are IL-4 and IL-5. These mediators and cytokines along with the acti-
vation of T-cell receptors leading to T-cell proliferation and differentiation into effector cells
that collectively contribute to protective responses against MAA.
MAP infection but not MAA results in activation of eosinophils via CCR3 signaling. Acti-
vated eosinophils release reactive oxygen species, which may cause tissue damage during
chronic inflammatory responses.
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In summary, the mechanism of infection duringMAP or MAA infectionmay be as follow:
our study revealed that perturbation of genes and cellular pathways duringMAP infectionwas
primarily focused on cell recruitment, cell proliferation and cell differentiation associated with
persistent infection. Contrarily, MAA infection was related to cellular responses associated
with activation of molecular pathways that produce chemicals and cytokines involved with the
containment of infection.We also found that the expressions of only TLR3 and TLR9 in our in
vivo study to be contradictory to those reported from in vitro studies, suggesting that the geno-
type of the pathogen and the site of infection in the intestinal environment plays a major role
in the pathogenic mechanisms of mycobacteria. By comparing the intestinal transcriptional
responses of calves infected with MAA versus MAP, unique patterns of expression were clearly
evident. The number of transcripts altered were somewhat greater for MAP-infected tissue
than for tissues infected with MAA. To interpret these complex data, changes in the gene
expression were further analyzed by dynamic Bayesian Gene Group Activation (DBGGA)
analysis and model interrogation methods. Bayesian network modeling identifiedmechanistic
genes and gene-to-gene relationships that are involved in specific cell activation duringMAP
or MAA infection. Furthermore, a major difference was found in the interaction between co-
stimulator molecules and T cell receptor signaling duringMAP and MAA infection.Our sys-
tems biology approach not only permitted deep analysis of global gene expression during
mycobacteria-induced innate immune responses, but also enabled prediction of the magnitude
of the subsequent adaptive immune response and proposed new correlates of transient vs. per-
sistent infection.
Overall, we found several distinct differences in the pathway, GO, and gene expression per-
turbations which allowed us to infer the mechanisms of invasion and evasion of the more per-
sistent MAP pathogen. The important conclusions and differences betweenMAP and MAA
are summarized in Fig 8(A) and 8(B) respectively. We propose that MAP has four immune
evasionmechanisms that help prolong its survival in the host, including: 1) weakening of the
mucosal immune barrier; 2) inhibition of the histocompatibility class II complex expression; 3)
reduction of phago-lysosomematuration; and 4) inhibition of Th1 host immune response in
favor of a Th2 response. In the transient MAA condition, the host had a strong innate immune
response favoring a Th1 bias and strong phagocytic activity.
Fig 8. (A) Depiction of the summaryconclusion for theMAP host immune and evasion responses. (B) Depiction of the summaryconclusion for the MAA host
immune response.
doi:10.1371/journal.pone.0161946.g008
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